John B. Thomas
Corporate Officer/Principal bei NIRI NY Chapter
Profil
John B.
Thomas is a professional with a background in investor relations and public affairs.
He is currently a member of the NIRI NY Chapter.
Previously, he held positions as Vice President of Investor Relations & Public Affairs at Abbott Laboratories from 1995 to 2013, SVP of Investor Relations & Corporate Communications at Assertio Therapeutics, Inc., and Executive VP of Strategy & Investor Relations at Horizon Therapeutics Plc from 2015 to 2017.
He also served as President of Abbott Fund.
Thomas received his undergraduate degree from the University of Mississippi in 1985 and his MBA from Lake Forest Graduate School of Management in 2001.
Aktive Positionen von John B. Thomas
| Unternehmen | Position | Beginn |
|---|---|---|
| NIRI NY Chapter | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von John B. Thomas
| Unternehmen | Position | Ende |
|---|---|---|
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Investor Relations Kontakt | 01.01.2017 |
| ABBOTT LABORATORIES | Investor Relations Kontakt | 01.05.2013 |
| Abbott Fund | Präsident | - |
Assertio Therapeutics, Inc.
 Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Investor Relations Kontakt | - |
| University of Mississippi | Corporate Officer/Principal | - |
Ausbildung von John B. Thomas
| University of Mississippi | Undergraduate Degree |
| Lake Forest Graduate School of Management | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Horizon Therapeutics Plc
 Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
| NIRI NY Chapter | |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Health Technology |
| Abbott Fund |
